News

Kenvue, Kirk Perry

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29
Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut Mongon has left the company and resigned from the Kenvue board. Perry, who joined Kenvue’s board of directors in December 2024,
Kirk Perry Appointed Interim CEO of Kenvue Amid Strategic Review
Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience. Of his appointment, Larry Merlo, Kenvue’s chair of
Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review
Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic review of the company.
Kenvue CEO Thibaut Mongon Steps Down, Director Kirk Perry To Take On Interim CEO Role
Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.
Kenvue (NYSE:KVUE) Appoints Kirk Perry As Interim CEO For Transformation Initiative
Kenvue (NYSE:KVUE) recently experienced a 2% price increase over the past week, a move that coincides with notable executive changes. The replacement of the CEO with Kirk L. Perry as interim CEO, along with the company's strategic review,
Kenvue CEO Departs As Company Launches Strategic Review
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.
Tylenol maker Kenvue ousts CEO amid board's strategic review
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it.
Kenvue Top Boss Thibaut Mongon Steps Down, Kirk Perry Named Interim CEO
Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing organisational review.
Kenvue shakeup: Interim CEO named amid strategic review
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
Kenvue's CEO Shake-up Amid Strategic Review
Kenvue, formerly part of Johnson & Johnson, announces CEO Thibaut Mongon's departure as it undergoes a strategic review. Board member Kirk Perry steps in as interim CEO as the company evaluates its portfolio and operational processes.
Tylenol-maker Kenvue fires CEO Thibaut Mongon, hires Kirk Pery as interim CEO
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim CEO on Monday.
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood
The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...
Barchart on MSN1d
Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?
Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a ...